Price must be right to list GLP-1s

Government committed to working with industry stakeholders and patients to support safe and sustainable access to medicines through the PBS, Minister says  An agreement on pricing is needed before glucagon-like peptide-1 (GLP-1) medications can be listed on the Pharmaceutical Benefits Scheme (PBS) for weight loss, Minister for Health, Disability and Ageing, Mark Butler says.   Responding to a petition